BamSEC and AlphaSense Join Forces
Learn More

ALX Oncology Holdings Inc. – Material Contracts

NASDAQ: ALXO    
Share price (6/23/26): $1.76    
Market cap (6/23/26): $237 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 8 pages Certain Exhibits and Schedules Have Been Omitted in Accordance With Regulation S-K Item 601(a)(5). the Registrant Agrees to Furnish Supplementally a Copy of Any Omitted Exhibit or Schedule to the SEC Upon Its Request, However the Registrant May Request Confidential Treatment of Omitted Items February 24, 2026 Jeff Knight via Email Re: Offer of Employment Dear Jeff: I Am Pleased to Offer You a Position With ALX Oncology Holdings Inc. (The “Company”) in Accordance With the Terms of This Offer of Employment Letter Agreement (The “Agreement”). 1
12/34/56
EX-10.12
from 10-K 13 pages ALX Oncology Holdings Inc. Change in Control and Severance Agreement
12/34/56
EX-10.10
from 10-K 9 pages Certain Exhibits and Schedules Have Been Omitted in Accordance With Regulation S-K Item 601(a)(5). the Registrant Agrees to Furnish Supplementally a Copy of Any Omitted Exhibit or Schedule to the SEC Upon Its Request, However the Registrant May Request Confidential Treatment of Omitted Items February 18, 2026 Barbara J. Klencke, M.D. via Email Re: Offer of Employment Dear Barbara: I Am Pleased to Offer You a Position With ALX Oncology Holdings Inc. (The “Company”) in Accordance With the Terms of This Offer of Employment Letter Agreement (The “Agreement”). 1
12/34/56
EX-10.1
from 8-K 44 pages ALX Oncology Holdings Inc. 2025 Inducement Equity Incentive Plan 1. Purpose of the Plan. the Purpose of This Plan Is to Attract and Retain the Best Available Personnel by Providing an Inducement Material to Individuals’ Entering Into Employment With the Company or Any Parent or Subsidiary of the Company
12/34/56
EX-10.3
from 10-Q 5 pages ALX Oncology Holdings Inc. Outside Director Compensation Policy (As Most Recently Amended and Restated Effective as of January 16, 2025 (The “Restatement Date”))
12/34/56
EX-10.2
from 10-Q 8 pages Certain Exhibits and Schedules Have Been Omitted in Accordance With Regulation S-K Item 601(a)(5). the Registrant Agrees to Furnish Supplementally a Copy of Any Omitted Exhibit or Schedule to the SEC Upon Its Request, However the Registrant May Request Confidential Treatment of Omitted Items. November 10, 2024 Alan Sandler, M.D. via Email Re: Offer of Employment Dear Alan
12/34/56
EX-10.1
from 10-Q 16 pages ALX Oncology Holdings Inc. Separation Agreement and Release
12/34/56
EX-10.19
from 10-K 5 pages ALX Oncology Holdings Inc. Outside Director Compensation Policy (As Most Recently Amended and Restated Effective as of January 16, 2025 (The “Restatement Date”))
12/34/56
EX-10.14
from 10-K 13 pages ALX Oncology Holdings Inc. Separation Agreement and Mutual Release This Separation Agreement and Mutual Release (“Agreement”) Is Made by and Between Peter Garcia (“Executive”) and ALX Oncology Holdings Inc. (The “Company”) (Collectively Referred to as the “Parties” or Individually Referred to as a “Party”)
12/34/56
EX-10.11
from 10-K 8 pages Certain Exhibits and Schedules Have Been Omitted in Accordance With Regulation S-K Item 601(a)(5). the Registrant Agrees to Furnish Supplementally a Copy of Any Omitted Exhibit or Schedule to the SEC Upon Its Request, However the Registrant May Request Confidential Treatment of Omitted Items October 11, 2024 Alan Sandler, M.D. via Email Re: Offer of Employment Dear Alan
12/34/56
EX-10.8
from 10-K 7 pages January 17, 2025 Harish Shantharam via Email Re: Offer of Employment Dear Harish
12/34/56
EX-10.1
from 8-K 43 pages ALX Oncology Holdings Inc. 2025 Inducement Equity Incentive Plan
12/34/56
EX-10.1
from 10-Q 12 pages ALX Oncology Holdings Inc. Separation Agreement and Release
12/34/56
EX-10.1
from 10-Q 7 pages Alx Oncology Holdings Inc. Amendment No. 1 to the Sales Agreement
12/34/56
EX-10.2
from 8-K 7 pages Material contract
12/34/56
EX-10.1
from 8-K 7 pages Material contract
12/34/56
EX-10.1
from 10-Q 5 pages Alx Oncology Holdings Inc. Outside Director Compensation Policy (As Amended and Restated Effective as of March 14, 2023 (The “Restatement Date”))
12/34/56
EX-10.6
from 10-K 6 pages Material contract
12/34/56
EX-10.11
from S-1/A 11 pages Alx Oncology Holdings Inc. Change in Control and Severance Agreement
12/34/56
EX-10.10
from S-1/A 4 pages Alx Oncology Holdings Inc. Outside Director Compensation Policy
12/34/56